Best Stocks Under $3 | Low-Priced Stocks for $3 or Less

1. Ur Energy NYSEAMERICAN:URG

$1.22 -0.03 (-2.40%)

Closing price 07/31/2026 04:10 PM Eastern

Extended Trading

$1.22 0.00 (0.00%)

As of 07/31/2026 07:57 PM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization: $484.81 million
Consensus Rating: Buy
Consensus Price Target: $2.36 (+93.3% Upside)
Volume: 7.20 million shares
Average Volume: 6.33 million shares
Today's Range: $1.20
▼
$1.27

2. iBio NASDAQ:IBIO

$1.40 +0.01 (+0.72%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$1.40 +0.01 (+0.36%)

As of 07/31/2026 07:34 PM Eastern

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization: $69.55 million
Consensus Rating: Buy
Consensus Price Target: $5.00 (+257.1% Upside)
Volume: 728,592 shares
Average Volume: 791,969 shares
Today's Range: $1.34
▼
$1.47

3. Inuvo NYSEAMERICAN:INUV

$0.92 -0.05 (-4.66%)

Closing price 07/31/2026 04:10 PM Eastern

Extended Trading

$0.92 +0.00 (+0.43%)

As of 07/31/2026 07:59 PM Eastern

Inuvo, Inc engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). More about Inuvo

Market Capitalization: $13.64 million
Consensus Rating: Buy
Consensus Price Target: $7.33 (+697.1% Upside)
Volume: 197,479 shares
Average Volume: 335,039 shares
Today's Range: $0.90
▼
$0.98

4. Microbot Medical NASDAQ:MBOT

$1.72 -0.02 (-1.15%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$1.70 -0.01 (-0.87%)

As of 07/31/2026 07:40 PM Eastern

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. More about Microbot Medical

Market Capitalization: $115.52 million
Consensus Rating: Buy
Consensus Price Target: $6.63 (+285.2% Upside)
Volume: 309,786 shares
Average Volume: 529,463 shares
Today's Range: $1.68
▼
$1.76

5. Inhibikase Therapeutics NASDAQ:IKT

$2.18 -0.10 (-4.39%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$2.17 -0.01 (-0.23%)

As of 07/31/2026 07:58 PM Eastern

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization: $287.83 million
Consensus Rating: Buy
Consensus Price Target: $5.40 (+147.7% Upside)
Volume: 369,546 shares
Average Volume: 994,381 shares
Today's Range: $2.13
▼
$2.29

6. Peraso NASDAQ:PRSO

$0.65 +0.01 (+0.78%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$0.64 -0.01 (-1.08%)

As of 07/31/2026 07:58 PM Eastern

Peraso Inc, a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules. More about Peraso

Market Capitalization: $9.55 million
Consensus Rating: Buy
Consensus Price Target: $3.00 (+363.0% Upside)
Volume: 262,642 shares
Average Volume: 313,334 shares
Today's Range: $0.61
▼
$0.68

7. Palisade Bio NASDAQ:PALI

$1.90 -0.07 (-3.32%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$1.88 -0.02 (-0.79%)

As of 07/31/2026 07:34 PM Eastern

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization: $328.93 million
Consensus Rating: Buy
Consensus Price Target: $9.00 (+374.9% Upside)
Volume: 1.85 million shares
Average Volume: 2.82 million shares
Today's Range: $1.86
▼
$1.95

8. Perspective Therapeutics NYSEAMERICAN:CATX

$2.91 -0.08 (-2.68%)

Closing price 07/31/2026 04:10 PM Eastern

Extended Trading

$2.92 +0.00 (+0.17%)

As of 07/31/2026 07:34 PM Eastern

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization: $331.87 million
Consensus Rating: Buy
Consensus Price Target: $12.63 (+333.8% Upside)
Volume: 827,579 shares
Average Volume: 1.48 million shares
Today's Range: $2.83
▼
$3.04

9. Stereotaxis NYSEAMERICAN:STXS

$1.26 -0.07 (-5.26%)

Closing price 07/31/2026 04:10 PM Eastern

Extended Trading

$1.29 +0.03 (+2.06%)

As of 07/31/2026 07:55 PM Eastern

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization: $123.40 million
Consensus Rating: Buy
Consensus Price Target: $3.88 (+207.5% Upside)
Volume: 719,183 shares
Average Volume: 1.35 million shares
Today's Range: $1.24
▼
$1.35

10. Ovid Therapeutics NASDAQ:OVID

$2.22 -0.15 (-6.33%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$2.22 -0.01 (-0.23%)

As of 07/31/2026 07:59 PM Eastern

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization: $414.34 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.13 (+130.9% Upside)
Volume: 1.74 million shares
Average Volume: 1.56 million shares
Today's Range: $2.20
▼
$2.36

11. Autolus Therapeutics NASDAQ:AUTL

$1.49 -0.04 (-2.61%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$1.50 +0.01 (+0.34%)

As of 07/31/2026 07:34 PM Eastern

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus Therapeutics

Market Capitalization: $396.57 million
Consensus Rating: Moderate Buy
Consensus Price Target: $8.75 (+487.2% Upside)
Volume: 815,255 shares
Average Volume: 1.08 million shares
Today's Range: $1.47
▼
$1.55

12. Context Therapeutics NASDAQ:CNTX

$0.60 -0.01 (-1.30%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$0.59 -0.01 (-1.74%)

As of 07/31/2026 07:54 PM Eastern

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization: $55.07 million
Consensus Rating: Moderate Buy
Consensus Price Target: $6.17 (+928.8% Upside)
Volume: 961,658 shares
Average Volume: 2.30 million shares
Today's Range: $0.58
▼
$0.61

13. Prime Medicine NASDAQ:PRME

$2.92 -0.10 (-3.31%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$2.94 +0.02 (+0.68%)

As of 07/31/2026 07:34 PM Eastern

We are a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying our Prime Editing technology, which we believe is a versatile, precise, efficient and broad gene editing technology. More about Prime Medicine

Market Capitalization: $527.40 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.53 (+157.9% Upside)
Volume: 1.83 million shares
Average Volume: 3.62 million shares
Today's Range: $2.91
▼
$3.04

14. InflaRx NASDAQ:IFRX

$1.70 -0.02 (-1.16%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$1.70 0.00 (0.00%)

As of 07/31/2026 07:34 PM Eastern

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. More about InflaRx

Market Capitalization: $122.90 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.00 (+311.8% Upside)
Volume: 583,912 shares
Average Volume: 948,056 shares
Today's Range: $1.64
▼
$1.76

15. Gold Royalty NYSEAMERICAN:GROY

$2.60 -0.09 (-3.35%)

Closing price 07/31/2026 04:10 PM Eastern

Extended Trading

$2.65 +0.05 (+1.92%)

As of 07/31/2026 07:34 PM Eastern

Gold Royalty Corp., a precious metals-focused royalty company, provides financing solutions to the metals and mining industry. More about Gold Royalty

Market Capitalization: $600.10 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.75 (+121.2% Upside)
Volume: 1.84 million shares
Average Volume: 1.78 million shares
Today's Range: $2.58
▼
$2.65

16. Real Brokerage NASDAQ:REAX

$1.60 -0.04 (-2.44%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$1.64 +0.04 (+2.81%)

As of 07/31/2026 07:35 PM Eastern

The Real Brokerage Inc, together with its subsidiaries, operates as a real estate technology company in the United States and Canada. More about Real Brokerage

Market Capitalization: $348.71 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.69 (+255.5% Upside)
Volume: 4.85 million shares
Average Volume: 3.81 million shares
Today's Range: $1.59
▼
$1.68

17. Compass Therapeutics NASDAQ:CMPX

$1.91 -0.03 (-1.55%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$1.91 0.00 (0.00%)

As of 07/31/2026 07:34 PM Eastern

Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass Therapeutics

Market Capitalization: $343.97 million
Consensus Rating: Moderate Buy
Consensus Price Target: $12.25 (+541.4% Upside)
Volume: 2.64 million shares
Average Volume: 2.23 million shares
Today's Range: $1.86
▼
$1.96

18. Nouveau Monde Graphite NYSE:NMG

$1.30 -0.03 (-1.89%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$1.33 +0.04 (+2.70%)

As of 07/31/2026 07:37 PM Eastern

Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde Graphite

Market Capitalization: $209.08 million
Consensus Rating: Moderate Buy
Consensus Price Target: $4.67 (+260.4% Upside)
Volume: 288,240 shares
Average Volume: 528,795 shares
Today's Range: $1.28
▼
$1.34

19. Denison Mine NYSEAMERICAN:DNN

$2.81 -0.11 (-3.77%)

Closing price 07/31/2026 04:10 PM Eastern

Extended Trading

$2.81 0.00 (0.00%)

As of 07/31/2026 07:54 PM Eastern

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization: $2.54 billion
Consensus Rating: Moderate Buy
Consensus Price Target: $5.38 (+91.3% Upside)
Volume: 22.35 million shares
Average Volume: 23.24 million shares
Today's Range: $2.75
▼
$2.97

20. Tenaya Therapeutics NASDAQ:TNYA

$0.74 -0.01 (-1.29%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$0.75 +0.01 (+1.58%)

As of 07/31/2026 07:51 PM Eastern

Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya Therapeutics

Market Capitalization: $160.64 million
Consensus Rating: Moderate Buy
Consensus Price Target: $4.00 (+440.3% Upside)
Volume: 1.61 million shares
Average Volume: 2.43 million shares
Today's Range: $0.72
▼
$0.77

21. Cellectis NASDAQ:CLLS

$2.75 -0.10 (-3.51%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$2.78 +0.02 (+0.91%)

As of 07/31/2026 04:04 PM Eastern

Cellectis SA, a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. More about Cellectis

Market Capitalization: $275.93 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.00 (+154.5% Upside)
Volume: 12,724 shares
Average Volume: 13,535 shares
Today's Range: $2.67
▼
$2.85

22. NervGen Pharma NASDAQ:NGEN

$1.62 +0.02 (+1.25%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$1.60 -0.02 (-1.23%)

As of 07/31/2026 07:34 PM Eastern

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. More about NervGen Pharma

Market Capitalization: $130.62 million
Consensus Rating: Moderate Buy
Consensus Price Target: $14.00 (+764.2% Upside)
Volume: 299,804 shares
Average Volume: 502,661 shares
Today's Range: $1.59
▼
$1.66

23. CuriosityStream NASDAQ:CURI

$2.44 +0.02 (+0.83%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$2.42 -0.02 (-0.94%)

As of 07/31/2026 07:38 PM Eastern

CuriosityStream Inc operates as a factual content streaming service and media company. The company provides premium video and audio programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via distributor's platform or system, as well as through bundled content licenses for SVoD and linear offerings, talks and courses, and partner bulk sales. More about CuriosityStream

Market Capitalization: $143.90 million
Consensus Rating: Moderate Buy
Consensus Price Target: $6.00 (+145.9% Upside)
Volume: 197,223 shares
Average Volume: 284,484 shares
Today's Range: $2.37
▼
$2.45

24. Nkarta NASDAQ:NKTX

$2.09 -0.06 (-2.79%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$2.10 +0.01 (+0.24%)

As of 07/31/2026 07:34 PM Eastern

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization: $149.53 million
Consensus Rating: Moderate Buy
Consensus Price Target: $10.75 (+414.4% Upside)
Volume: 683,232 shares
Average Volume: 737,843 shares
Today's Range: $2.05
▼
$2.18

25. Equillium NASDAQ:EQ

$2.20 -0.12 (-5.17%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$2.24 +0.04 (+2.00%)

As of 07/31/2026 07:56 PM Eastern

Equillium, Inc, a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. More about Equillium

Market Capitalization: $139.10 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.57 (+244.2% Upside)
Volume: 729,000 shares
Average Volume: 676,226 shares
Today's Range: $2.18
▼
$2.37

Best Stocks Under $3 Right Now

1. Ur Energy NYSEAMERICAN:URG

2. iBio NASDAQ:IBIO

3. Inuvo NYSEAMERICAN:INUV

4. Microbot Medical NASDAQ:MBOT

5. Inhibikase Therapeutics NASDAQ:IKT

6. Peraso NASDAQ:PRSO

7. Palisade Bio NASDAQ:PALI

8. Perspective Therapeutics NYSEAMERICAN:CATX

9. Stereotaxis NYSEAMERICAN:STXS

10. Ovid Therapeutics NASDAQ:OVID

11. Autolus Therapeutics NASDAQ:AUTL

12. Context Therapeutics NASDAQ:CNTX

13. Prime Medicine NASDAQ:PRME

14. InflaRx NASDAQ:IFRX

15. Gold Royalty NYSEAMERICAN:GROY

16. Real Brokerage NASDAQ:REAX

17. Compass Therapeutics NASDAQ:CMPX

18. Nouveau Monde Graphite NYSE:NMG

19. Denison Mine NYSEAMERICAN:DNN

20. Tenaya Therapeutics NASDAQ:TNYA

21. Cellectis NASDAQ:CLLS

22. NervGen Pharma NASDAQ:NGEN

23. CuriosityStream NASDAQ:CURI

24. Nkarta NASDAQ:NKTX

25. Equillium NASDAQ:EQ

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Stocks Under $3 Right Now

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools